Cargando…
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
OBJECTIVES: To determine the seroprevalence of anti-SARS-CoV-2 IgG and IgM antibodies in symptomatic Japanese COVID-19 patients. METHODS: Serum samples (n = 114) from 34 COVID-19 patients with mild to critical clinical manifestations were examined. The presence and titers of IgG antibody for severe...
Autores principales: | Hiki, Makoto, Tabe, Yoko, Ai, Tomohiko, Matsue, Yuya, Harada, Norihiro, Sugimoto, Kiichi, Matsushita, Yasushi, Matsushita, Masakazu, Wakita, Mitsuru, Misawa, Shigeki, Idei, Mayumi, Miida, Takashi, Tamura, Naoto, Takahashi, Kazuhisa, Naito, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023454/ https://www.ncbi.nlm.nih.gov/pubmed/33822809 http://dx.doi.org/10.1371/journal.pone.0249449 |
Ejemplares similares
-
Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity
por: Tsuchiya, Koji, et al.
Publicado: (2022) -
Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo
por: Igawa, Gene, et al.
Publicado: (2022) -
SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Fukuda, Hiroshi, et al.
Publicado: (2021) -
Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Fukuda, Hiroshi, et al.
Publicado: (2021) -
Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment
por: Takei, Satomi, et al.
Publicado: (2022)